Mode
Text Size
Log in / Sign up

MDRO detection rates increased during COVID-19 policy phases in Chinese inpatients with hospital-acquired infections.

MDRO detection rates increased during COVID-19 policy phases in Chinese inpatients with hospital-acq…
Photo by Ayanda Kunene / Unsplash
Key Takeaway
Consider monitoring MDRO trends and risk factors in hospitalized patients during policy shifts.

This retrospective cohort study analyzed 2,669 adult inpatients with culture-confirmed hospital-acquired infections at a Chinese tertiary hospital from 2013 to 2023, stratified into pre-pandemic, strict containment, and post-adjustment phases related to COVID-19 policies. The intervention or exposure was these policy phases and specific risk factors, including male sex, age ≥60 years, prolonged hospitalization, mechanical ventilation, urinary catheter use, and endotracheal intubation, compared across phases and against other factors.

Main results showed the MDRO detection rate increased from 36.9% to 56.4%, though exact numbers and statistical significance were not reported. The dominant resistant pathogen shifted, with CRAB progressively overtaken by CRE, and Klebsiella pneumoniae became predominant in 2022. Bloodstream infections increased from 24% to 32%. Risk factor analyses indicated mechanical ventilation was associated with increased odds of CRAB infection (aOR=2.07, 95% CI: 1.36-3.16), urinary catheter use with increased odds of CRE infection (aOR=1.49, 95% CI: 1.06-2.09) but lower odds of CRAB infection (aOR=0.64, 95% CI: 0.46-0.89), and endotracheal intubation with increased odds of VRE infection (aOR=5.84, 95% CI: 1.10-30.9).

Safety and tolerability data were not reported. Key limitations were not specified in the input, but as an observational study, it cannot establish causality, and details like follow-up, funding, and conflicts were not reported. In practice, this evidence may support risk stratification and more targeted infection prevention strategies in high-risk hospitalized patients, but clinicians should interpret findings with caution due to the retrospective design and lack of reported statistical measures for some outcomes.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundMultidrug-resistant organism (MDRO) infections are a major global health threat. The COVID-19 pandemic and related containment policies may have altered hospital infection epidemiology and the distribution of MDROs.MethodsIn this retrospective cohort study, clinical and microbiological data from 2,669 adult inpatients with culture-confirmed hospital-acquired infections between 2013 and 2023 were analyzed. MDROs were defined per CLSI guidelines. The study period was stratified into pre-pandemic, strict containment, and post-adjustment phases. Multivariate logistic regression was used to identified factors associated with specific MDRO infections.ResultsThe overall MDRO detection rate increased from 36.9% to 56.4% during the strict containment. CRAB, which had previously been the dominant resistant pathogen, was progressively overtaken by CRE, while Klebsiella pneumoniae became the predominant species in 2022 (40.0%).Bloodstream infections increased from a pre-pandemic peak of 24% to 32% during the strict containment phase. Male sex, age≥60 years, and prolonged hospitalization (>14 days) were associated with distinct distribution patterns of CRAB and CRE infection. In multivariable analyses, mechanical ventilation was associated with increased odds of CRAB infection (aOR=2.07, 95% CI: 1.36-3.16), while urinary catheter use was associated with increased odds of CRE infection (aOR=1.49, 95% CI: 1.06-2.09) but lower odds of CRAB infection (aOR=0.64, 95% CI: 0.46-0.89). Endotracheal intubation was associated with increased odds of VRE infection (aOR = 5.84, 95% CI: 1.10-30.9).ConclusionsHospital MDRO epidemiology shifted substantially across the COVID-19 policy phases, with CRE emerging as the dominant resistant pathogen. Specific invasive procedures showed pathogen-specific associations, supporting risk stratification and more targeted infection prevention strategies in high-risk hospitalized patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.